"Medsol clinical Research Center is an independent stand alone research site located in Port Charlotte, Florida conducting phase I, II, III, and IV clinical trials for pharmaceutical and biotechnology companies in neurology, internal medicine, and pulmonology."

During the past decade, Medsol Clinical Research Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medsol Clinical Research Center" #1 sponsor was "Sunovion" with 3 trials, followed by "Takeda" with 3 trials sponsored, "Enterin Inc." with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Wex Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medsol Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "LGC Limited" with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Medsol Clinical Research Center" are "Constipation" (2 trials), "Epilepsy" (2 trials), "Myasthenia Gravis" (2 trials), "Bacterial Conjunctivitis" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "Medsol Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Medsol Clinical Research Center" are "Drug" (21 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Eslicarbazepine acetate" (3 trials), "Tetrodotoxin" (2 trials), "placebo" (2 trials) and "1200 mg QD Eslicarbazepine acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medsol Clinical Research Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Medsol Clinical Research Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Medsol Clinical Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medsol Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".